跳至主導覽
跳至搜尋
跳過主要內容
臺北醫學大學 首頁
說明與常見問題
English
中文
首頁
專家檔案
研究單位
專案
研究成果
資料集
活動
按專業知識、姓名或所屬機構搜尋
神經醫學博士學位學程
臺北醫學大學
醫學科技學院
電話
+886-2-27361661#7604
電子郵件
[email protected]
網站
http://nrm.tmu.edu.tw/
郵寄地址
在地圖上顯示
No. 250 Wu-Xing Street
11031
Taipei
概覽
指紋
網路
專家檔案
(28)
專案
(209)
研究成果
(2336)
資料集
(108)
指紋
查看啟用 神經醫學博士學位學程 的研究主題。這些主題標籤來自此機構會員的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Mouse
80%
Disease
66%
Neoplasm
65%
Brain Ischemia
61%
Cohort Study
58%
Glioblastoma
57%
Antiplatelet
54%
Parkinson's Disease
52%
Traumatic Brain Injury
40%
Inflammation
39%
Mitogen Activated Protein Kinase
38%
Cyclooxygenase 2
38%
Injury
36%
Protein Kinase C
33%
Antioxidant
33%
Lung Cancer
32%
Breast Cancer
32%
Neuroprotective Agent
31%
Lipopolysaccharide
31%
Tumor Necrosis Factor
30%
Temozolomide
27%
Reactive Oxygen Metabolite
27%
Alzheimer's Disease
27%
Protein P53
26%
Triflavin
25%
Mitogen Activated Protein Kinase P38
24%
Colon Cancer
24%
Cardiovascular Disease
23%
Nuclear Factor
23%
Cytotoxicity
22%
Calcium Ion
22%
Thrombin
22%
Epidermal Growth Factor Receptor
22%
Epidermal Growth Factor
21%
Carcinogenesis
20%
Western Blot
20%
Alternative Complement Pathway C3 C5 Convertase
19%
Nicotinic Receptor
19%
Nitric Oxide
19%
Well Water
19%
Phosphotransferase
18%
Metastasis
18%
Anticoagulant Agent
18%
Chronic Kidney Failure
17%
Integrin
17%
Combination Therapy
17%
Adenosine Triphosphate
17%
Mouse Model
17%
Arachidonic Acid
16%
Diabetes Mellitus
16%
Inducible Nitric Oxide Synthase
16%
Mitogen Activated Protein Kinase 3
16%
Thrombosis
16%
Middle Cerebral Artery Occlusion
16%
Cyclic AMP
16%
Biological Marker
16%
Adverse Event
15%
Lipoteichoic Acid
15%
Cigarette Smoking
15%
Histone Deacetylase Inhibitor
15%
Acetylsalicylic Acid
15%
Andrographolide
15%
CCAAT Enhancer Binding Protein Delta
15%
Cancer Growth
15%
Hydroxyl Radical
15%
Liver Cell Carcinoma
14%
Cytokine
14%
Artery Thrombosis
14%
Free Radical
14%
Colorectal Cancer
14%
Clinical Trial
14%
Prevalence
14%
Bladder Cancer
13%
Chemotherapy
13%
Caspase 3
13%
Heme Oxygenase 1
13%
Thromboembolism
13%
Squamous Cell Carcinoma
13%
Neuroprotection
13%
Anti-Inflammatory Drug
13%
Lipoxygenase
13%
Head Injury
12%
Gelatinase B
12%
Transitional Cell Carcinoma
12%
Brain Hemorrhage
12%
Symptom
12%
Phospholipase C
12%
Glutathione
12%
Nervous System Inflammation
12%
Ischemia
12%
Carotid Atherosclerosis
12%
Randomized Controlled Trial
12%
Tumor Growth
12%
Cyclic GMP
11%
Cognitive Defect
11%
Dose-Response Relationship
11%
Arginylglycylaspartic Acid
11%
Interleukin 1
11%
Long Term Exposure
11%
Medicine and Dentistry
Apoplexy
86%
Cohort Analysis
55%
Brain Ischemia
43%
Parkinson's Disease
39%
Disease
38%
Traumatic Brain Injury
37%
Malignant Neoplasm
34%
Platelet
33%
Injury
33%
Neoplasm
33%
Glioblastoma
32%
Cancer Cell
32%
Breast Cancer
29%
In Vitro
28%
Hazard Ratio
25%
Alzheimer's Disease
24%
Symptom
24%
Odds Ratio
24%
Metastatic Carcinoma
23%
Diabetes
21%
Meta-Analysis
21%
Programmed Cell Death
19%
Magnetic Resonance Imaging
19%
Signal Transduction
17%
Diabetes Mellitus
17%
Ganglioglioma
17%
Cerebral Hemorrhage
17%
Drug Therapy
16%
Biological Marker
16%
Rehabilitation Engineering
15%
Gene Expression
15%
Thrombocyte Aggregation
15%
Prevalence
14%
Retrospective Cohort Study
14%
Lung Cancer
14%
Thrombocyte Activation
14%
Spinal Cord Injury
14%
Functional Electrical Stimulation
14%
Quality of Life
13%
Medicine
13%
Randomized Controlled Trial
13%
Cell Proliferation
12%
Antithrombotic
12%
Bladder
12%
Systematic Review
12%
Adverse Event
11%
Tumor Necrosis Factor
11%
Temozolomide
11%
Chronic Kidney Disease
11%
down Regulation
11%
Cyclooxygenase 2
11%
Reactive Oxygen Species
11%
Closed Head Injury
10%
Antiplatelet
10%
Combination Therapy
10%
Case-Control Study
10%
Proportional Hazards Model
10%
Kawasaki Disease
10%
Cancer
10%
Infection
10%
Cell Migration
10%
Mitogen-Activated Protein Kinase
10%
Blood Clot Lysis
10%
Epithelial Cell
10%
Disability
9%
Carcinogenesis
9%
Integrin
9%
Maturity Onset Diabetes of the Young
9%
Clinical Trial
9%
Survival Rate
9%
Ischemia
9%
Percutaneous Vertebroplasty
8%
4 Iodo 2,5 Dimethoxyamphetamine
8%
Epidermal Growth Factor Receptor
8%
Activities of Daily Living
8%
Electrical Brain Stimulation
8%
Urination
8%
Cyberknife
8%
Upregulation
8%
Neurologic Disease
8%
Plasminogen Activator Inhibitor-1
8%
Health Care Cost
8%
Cognitive Defect
8%
Urinary System
8%
Colorectal Cancer
8%
Tumor Cell
8%
COVID-19
8%
Motor Performance
7%
Amyloid
7%
Electrostimulation
7%
Cognition
7%
Visual Analog Scale
7%
Infarction
7%
Cigarette Smoking
7%
Degenerative Disease
7%
Alteplase
7%
Radiosurgery
7%
Calcium Ion
7%
Stem Cell
7%
Protein Expression
7%
Biochemistry, Genetics and Molecular Biology
Cancer Cell
70%
Mouse
47%
Platelet
43%
Gene Expression
39%
Promoter Region
35%
Thrombocyte Activation
32%
Signal Transduction
29%
Single-Nucleotide Polymorphism
27%
Messenger RNA
26%
Thrombocyte Aggregation
24%
Cohort Study
23%
Cell Migration
23%
Cyclooxygenase
22%
Genetics
21%
P53
21%
Cell Proliferation
21%
Carcinogenesis
19%
Epidermal Growth Factor Receptor
19%
Transcription
18%
Protein Expression
18%
MicroRNA
17%
Macrophage
17%
Mitogen-Activated Protein Kinase
17%
Genotyping
17%
down Regulation
17%
Colon
16%
Upregulation
16%
Phosphotransferase
16%
Kinase
16%
Epidermal Growth Factor
15%
P38 Mitogen-Activated Protein Kinases
15%
Oxidative Stress
15%
CCAAT Enhancer Binding Protein Delta
15%
Cell Death
14%
Allele
14%
Eicosanoid Receptor
13%
Stem Cell
13%
Sp1 Transcription Factor
13%
Cyclic Adenosine Monophosphate
12%
Protein Kinase C
12%
Genetic Divergence
12%
Amyloid
12%
Genetic Polymorphism
12%
A431 Cells
12%
Anticancer
12%
Lipoxygenase
12%
Extracellular Signal-Regulated Kinases
12%
Autophagy
12%
Histone Deacetylase
11%
Western Blot
11%
Mesenchymal-Epithelial Transition
10%
Genome-Wide Association Study
10%
Heme Oxygenase
10%
Tau
10%
Dopaminergic
10%
Superoxide Dismutase
10%
Gene Promoter
10%
Low Drug Dose
9%
Integrin
9%
Methylation
9%
Bone Density
9%
Agonist
9%
Survival Rate
9%
Drug Resistance
9%
P21
9%
Tumor Progression
9%
Ubiquitin
9%
Nitric Oxide Synthase
8%
Mitochondrion
8%
Thrombin
8%
ORAI1
8%
Prevalence
8%
Enzyme
8%
Lipopolysaccharide
8%
Cyclic Nucleotide
8%
Genetic Determinism
8%
MMP9
8%
Gelatinase B
8%
Estrogen Receptor
8%
Catenin
8%
N-Terminus
8%
Adenosine Triphosphate
7%
C-Terminus
7%
Cell Cycle
7%
Clinical Trial
7%
STAT3
7%
Metabolic Pathway
7%
Fibroblast
7%
Cancer Stem Cell
7%
Wild Type
7%
Animal Model
7%
Synapsin I
7%
Cytotoxicity
7%
Heat Shock Protein
7%
Binding Site
7%
Hydrogen Peroxide
7%
Antioxidant Enzyme
7%
Catalase
7%
Tumor Suppressor Protein
7%
Phospholipase C
7%